THE “HEAD START 4” PROTOCOL- NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS: CLINICAL AND MOLECULAR RISK-TAILORED INTENSIVE AND COMPRESSED INDUCTION CHEMOTHERAPY FOLLOWED BY
Summary
Doctors would like to look at tumor tissue and blood samples from patients with brain tumors to learn more about childhood tumors. In the future, the information they learn may help to find out better ways to find tumors early, prevent tumors, and develop better therapies with fewer side effects.
This research study has two parts. The first part of the study is called Induction. During induction, you will be given either 3 cycles or 5 cycles of chemotherapy. You will also have a procedure performed called leukapheresis in which some of your own blood cells are collected and stored for later use.
The second part of the research study is called Consolidation. Before the start of Consolidation, you will need to finish the Induction part. You will be asked to sign another assent form if you go on to the Consolidation.
Eligibility
Eligible ages: 0 to 10
Inclusion criteria:
Newly Diagnosed Children Less Than 10 Years Old With Medulloblastoma And Other Central Nervous System Embryonal Tumors.
Exclusion criteria:
MUST meet inclusion criteria.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Recruitment through hospital referral only
Principal investigator:
Lucie Lafay-Cousin
Clinical trial:
Yes
REB-ID:
HREBA.CC-17-0327